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2001 ASHG AWARD FOR EXCELLENCE IN EDUCATION
Introductory Speech for Charles Scriver*
David Valle
Most here today would summarize their professional
activities under some combination of three broad cate-
gories: research, clinical practice, and education. Unfor-
tunately, in these times when researchers are faced with
an overwhelming flood of new information and when
clinicians are under increasing pressure to see more and
more patients, education all too often ends up at the
bottom of the priority list. This, despite the fact that
there is no activity more important than education of
our colleagues, the public, and especially our students,
the geneticists of the next generation. Thus, it is my
distinct pleasure and honor to introduce someone who
has put education at the top of his list, the recipient of
this year’s Award for Excellence in Education, my col-
league, friend, and advisor, Charles Scriver.
Charles is well known to you all, so I will mention
only a few key points of his history. He was born in
Montreal into a scholarly family; both his parents were
academic physicians. He received all his formal training
at McGill, graduating cum laude with a B.A. in 1951
and with an M.D. in 1955. Over the next 3 years, he
completed a pediatric residency, also at McGill, and
then, in 1958, began his career in biochemical genetics
with a 2-year fellowship with Professor C. E. Dent at
University College in London, where he was exposed to
exciting early work on disorders of amino acid transport.
In 1960, he returned to Montreal to complete a chief
residency in pediatrics at McGill, and the rest, as they
say, is history. Charles has now published more than
300 papers and numerous reviews and books and is a
fellow of the Royal Society and the Royal Society of
Canada.
Throughout his career, Charles has been involved in
education. Images over the years from the Bar Harbor
course, taken by Victor McKusick, document this point
(fig. 1). Thus, when Vasken der Kaloustian called to ask
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if I would second his nomination of Charles for the
Award for Excellence in Education, I was thrilled to do
so. Of Charles’s many educational contributions, I will
emphasize several of particular relevance to his selection
and to me.
First, from the early 1960s, Charles has played amajor
role in establishing the field of modern biochemical ge-
netics. His initial publications on disorders of proline
and glutamate metabolism and inborn errors of amino
acid transport contributed enormously to the early ex-
citement that drove the growth of the specialty. Partic-
ularly important, from an educational perspective, was
the slender book that he and Leon Rosenberg coauth-
ored, Amino Acid Metabolism and Its Disorders (Scriver
and Rosenberg 1973). This monograph contains exten-
sive information on normal amino acid biochemistry and
physiology, together with chapters on the clinical and
metabolic aspects of the abnormal phenotypes. Although
Figure 1 Charles Scriver teaching at the “Bar Harbor Course”
in 1972 (a) and 1987 (b). Photos courtesy of Victor McKusick.
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Figure 2 A full set of The Metabolic and Molecular Bases of
Inherited Disease. Charles Scriver has been the senior editor for the
last three editions: the 6th (red), the 7th (blue), and the 8th (green).
Figure 3 The editors of The Metabolic and Molecular Bases of
Inherited Disease in 1989, when the 6th edition had just appeared and
the 7th was in planning. Charles Scriver is second from the right.
currently out of print, it remains the best available sum-
mary of amino acid physiology and, over the years, has
contributed to the training of two or more generations
of biochemical geneticists.
A second major contribution has been Charles’s work
in the areas of patient and community education. An
excellent example is his work on Tay-Sachs and thal-
assemia screening and education in Quebec. In a beau-
tiful and comprehensive study described in a series of
papers, Charles developed and tested Tay-Sachs and
thalassemia screening and educational programs tar-
geted at high school students, reasoning that this is an
age when people are highly concerned with their own
biology and would be most receptive to this information.
Follow-up evaluation of the first 20 years of this effort
indicated that the vast majority of those tested correctly
retained knowledge of their carrier status and used this
information in their family planning (Mitchell et al.
1996). This program contributed to a 190% reduction
in the incidence of these two diseases in Quebec, an
outstanding example of successful education of an entire
population about the value of genetic medicine.
A third educational focus of Charles’s work has been
his ongoing interest in treatment of genetic diseases. To-
gether with Barton Childs, a previous recipient of this
award, Charles has been responsible for a series of stud-
ies evaluating treatment of genetic disease over the last
25 years (Costa et al. 1985; Hayes et al. 1985; Treacy
et al. 1995). This work has emphasized the enormous
challenges involved in our attempts to treat genetic dis-
ease and has provided a metric by which we canmeasure
our progress to this end.
More recently, Charles has been deeply involved in ed-
ucating all of us about the challenge of understanding
complex traits—the next frontier of genetic medicine. His
strategy, not surprisingly, has been to use a “simple”
monogenic disorder, phenylketonuria (PKU), as an ex-
ample of a complex trait. Delving deep into PKU and
phenylalanine hydroxylase, he has shown how multiple
genetic and environmental factors interact to influence the
phenotype of mutations at the PAH locus (Scriver and
Waters 1999). This work, based on a disorder we think
we understand, provides a conceptual framework for
those we clearly don’t. As part of this effort, Charles
quickly recognized the potential of cyberspace for genetic
education. His phenylalanine hydroxylase locus know-
ledgebase (PAHdb) is a superb online relational resource,
useful not only to workers in the field but also as a model
to all who use mutations and mutant phenotypes as a
way to understand genetics. It also provides extensive
educational material for PKU patients and families.
Last, I would emphasize the enormous contributions
Charles has made as the senior editor of the last three
editions (6th, 7th, and 8th) of The Metabolic and Mo-
lecular Bases of Inherited Disease (fig. 2). Without his
guidance, expertise, and energy, the book might not have
survived transition of its editorial leadership (fig. 3). Nor
would it have expanded in scope from straightforward
coverage of classical inborn errors of metabolism to a
compendium on all genetic medicine. I am clearly biased
here, but I would argue that Charles’s efforts on this book
alone are an invaluable educational accomplishment.
In summary, Charles has served as a model for all of
us with his unflagging, diverse, and highly successful
educational activities. He is a wonderful choice as this
year’s recipient of the ASHG Award for Excellence in
Education.
Electronic-Database Information
The URL for data in this article is as follows:
PAHdb, http://data.mch.mcgill.ca/pahdb_new/
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